Evidence map›Paper›PMID 37025939›Full record

ArticleCirculation reports2023

Duration of Initial Intensive Rivaroxaban Therapy for Patients With Venous Thromboembolism　- Subanalysis of the J'xactly Study.

Mashio Nakamura, Ikuo Fukuda, Norikazu Yamada, Morimasa Takayama, Hideaki Maeda, Takeshi Yamashita, Takanori Ikeda, Makoto Mo, Tsutomu Yamazaki, Yasuo Okumura and 2 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

Mashio NakamuraNakamura Medical Clinic Kuwana Japan.
Ikuo FukudaDepartment of Cardiology, Keimeikai Yokawa Hospital Miki Japan.
Norikazu YamadaDepartment of Cardiology, Kuwana City Medical Center Kuwana Japan.
Morimasa TakayamaDepartment of Cardiology, Sakakibara Heart Institute Fuchu Japan.
Hideaki MaedaDepartment of Heart and Vascular Center, Ukima Central Hospital Tokyo Japan.
Takeshi YamashitaDepartment of Cardiovascular Medicine, The Cardiovascular Institute Tokyo Japan.
Takanori IkedaDepartment of Cardiovascular Medicine, Toho University Faculty of Medicine Tokyo Japan.
Makoto MoDepartment of Cardiovascular Surgery, Yokohama Minami Kyosai Hospital Yokohama Japan.
Tsutomu YamazakiInnovation and Research Support Center, International University of Health and Welfare Tokyo Japan.
Yasuo OkumuraDivision of Cardiology, Department of Medicine, Nihon University School of Medicine Tokyo Japan.
Atsushi HirayamaDepartment of Cardiology, Osaka Police Hospital Osaka Japan.
J’xactly Investigators
Cardiovascular Institute Hospital · JPInternational University of Health and Welfare · JPNihon University · JPOsaka Police Hospital · JPSakakibara Hospital · JPSunagawa City Medical Center · JPToho University · JPYokohama Minami Kyosai Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Deep vein thrombosisPulmonary embolismReal-world surveyRivaroxabanVenous thromboembolism

Identifiers

PMID37025939
PMCPMC10072900
OpenAlexW4360603881

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.